Why are beta-blockers avoided in cocaine toxicity?

Why are beta-blockers avoided in cocaine toxicity?

• A. They may cause unopposed alpha vasoconstriction
• B. They cause excessive sedation
• C. They worsen tachycardia
• D. They interact with benzodiazepines

Answer: (A)

Cocaine toxicity drives a surge of sympathetic activity by increasing norepinephrine at nerve endings, which strongly stimulates alpha-adrenergic receptors on blood vessels and alpha-mediated vasoconstriction. If you give beta-blockers, you blunt the beta-adrenergic effects (like heart rate and some vasodilation) but you do not directly counteract the alpha-driven vasoconstriction. The result can be unopposed alpha-adrenergic activity, leading to worsening hypertension, severe vasoconstriction, and an increased risk of myocardial ischemia or stroke. That’s why beta-blockers are avoided in this setting. Instead, treatment focuses on reducing sympathetic outflow with benzodiazepines, and using vasodilators or alpha-blockers (such as nitroglycerin, calcium channel blockers, or, in select cases, phentolamine or a combined alpha-beta blocker like labetalol) to counteract the vasoconstriction.

Cocaine toxicity drives a surge of sympathetic activity by increasing norepinephrine at nerve endings, which strongly stimulates alpha-adrenergic receptors on blood vessels and alpha-mediated vasoconstriction. If you give beta-blockers, you blunt the beta-adrenergic effects (like heart rate and some vasodilation) but you do not directly counteract the alpha-driven vasoconstriction. The result can be unopposed alpha-adrenergic activity, leading to worsening hypertension, severe vasoconstriction, and an increased risk of myocardial ischemia or stroke.

That’s why beta-blockers are avoided in this setting. Instead, treatment focuses on reducing sympathetic outflow with benzodiazepines, and using vasodilators or alpha-blockers (such as nitroglycerin, calcium channel blockers, or, in select cases, phentolamine or a combined alpha-beta blocker like labetalol) to counteract the vasoconstriction.